Health

  • June 08, 2026

    Trump's $100K H-1B Fee Is Unauthorized Tax, Judge Rules

    A Massachusetts federal judge ruled Monday that President Donald Trump's $100,000 H-1B visa payment constitutes a tax that Congress did not authorize the president to impose, declaring the fee unlawful and vacating it in its entirety.

  • June 08, 2026

    Sleep Aid Buyers Say 'Non-Habit' Pills Can Cause Dependence

    A proposed class of sleep-aid buyers is suing the makers and sellers of Unisom, saying that despite being marketed with a prominent "non-habit forming" claim, its main ingredient has been known to lead to dependence with frequent use.

  • June 08, 2026

    Insurance Brokerage GoHealth Hits Ch. 11 With Prepack Plan

    Health insurance broker GoHealth has filed for Chapter 11 protection in Delaware with $772 million in debt and a prepack equity-swap plan, saying medical costs are outpacing government reimbursement and that it is facing litigation alleging its involvement in a kickback scheme.

  • June 05, 2026

    Ex-Trader Accused Of Profiting From Cousin's Insider Info

    A retired New York Mercantile Exchange trader is charged with insider trading by securities regulators who allege he bought shares of Sanofi's biopharmaceutical unit Kadmon Holdings Inc. based on confidential information the trader received about Kadmon's flagship chronic graft-versus-host disease treatment drug in July 2021, and that the trader tipped off a friend about the information.

  • June 05, 2026

    HHS Can Issue Medicare Fines Without Jury, 4th Circ. Says

    The Fourth Circuit ruled Friday that the U.S. Department of Health and Human Services can seek monetary penalties from Medicare participants for violating program requirements without a jury trial, rejecting a Maryland nursing home operator's argument that Medicare participants are guaranteed that right.

  • June 05, 2026

    JPML Denies Industrywide Spinal Device Injury MDL Bid

    The Judicial Panel on Multidistrict Litigation declined to consolidate dozens of product liability cases over spinal cord stimulator devices manufactured by Boston Scientific Corp., Abbott Laboratories, Nevro and Medtronic, finding Friday that while centralization of the actions against Boston Scientific was appropriate, an industrywide action was not.

  • June 05, 2026

    Trans Patients Urge Blocking DOJ 'Campaign Of Harassment'

    Transgender adolescents urged a California federal judge Friday to block a Stanford Medicine hospital from sharing gender-related care medical records in response to a Texas grand jury criminal subpoena, arguing that other courts have rebuffed similar government subpoena attempts and the judge should end the DOJ's "campaign of harassment."

  • June 05, 2026

    NM Jury Awards $13M To 'Star Trek' Star's Family In Death Suit

    A New Mexico jury has awarded $13 million to the family of Nichelle Nichols, who played Lt. Uhura on "Star Trek," in a medical malpractice suit accusing a hospital of causing the trailblazing actress's death in 2022, according to news reports.

  • June 05, 2026

    IRhythm Inks $45M Deal With Investors In Heart Device Suit

    IRhythm Technologies Inc. investors asked a California federal judge to preliminarily greenlight a $45 million settlement resolving allegations the digital healthcare company inflated stock prices with misrepresentations about its heart-event monitoring device, noting the deal is a favorable result that warrants approval, given the possibility of no recovery. 

  • June 05, 2026

    Healthcare Analyst Charged In 'Wall-Crossing' Insider Case

    A healthcare-sector securities analyst took in $350,000 by trading on insider information he received after being cleared to access company secrets in a process called "wall-crossing," federal prosecutors in Manhattan charged Friday.

  • June 05, 2026

    ​​​​​​​Judge Seeks Discipline For DOJ Trans Care Subpoena Tactics

    A Rhode Island federal judge on Friday referred Justice Department attorneys seeking gender-affirming care records from Rhode Island Hospital via a HIPAA subpoena to a court disciplinary committee for potential punishment after they allegedly misled the court. 

  • June 05, 2026

    Sanofi Eczema Drug Suits Consolidated, Sent To NJ Fed Court

    The Judicial Panel on Multidistrict Litigation has sent to federal court in New Jersey suits against Regeneron Pharmaceuticals and Sanofi-Aventis alleging the eczema drug Dupixent causes a rare type of non-Hodgkin lymphoma.

  • June 05, 2026

    Colo. Panel Says Medical POA Doesn't Extend To Arbitration

    A medical power of attorney does not let an agent agree to arbitration unless that power is expressly granted, a Colorado appeals panel held, affirming a nursing home's loss in its bid to force arbitration in a negligence and wrongful death suit.

  • June 05, 2026

    CMS Hemp Program Foes Take Standing Fight To DC Circ.

    A group challenging a Centers for Medicare & Medicaid Services program to give patients access to federally legal hemp products will bring their case to the D.C. Circuit Court of Appeals after a federal judge tossed their petition for lack of standing last month.

  • June 05, 2026

    Health Funds Ink $5.5M Generic Drug Deal With Breckenridge

    A proposed class of end-payers who allegedly overpaid for generic drugs have asked a federal court for preliminary approval of a $5.5 million settlement with Breckenridge Pharmaceutical Inc., though notifying class members and seeking final approval would wait until the process could be combined with another settlement, the plaintiffs said Thursday.

  • June 05, 2026

    In Industry First, Cannabis Co. Trulieve Will List On NYSE

    Multistate marijuana company Trulieve Cannabis Corp. announced Friday that in response to a Trump administration rule loosening federal restrictions on medical cannabis, it would be listed on the New York Stock Exchange beginning next week, a first for the marijuana industry.

  • June 05, 2026

    Don't Miss It: Hogan Lovells, Cooley Steer Hot Deals

    A lot can happen in the world of mergers and acquisitions and equity fundraising over the course of a couple of weeks, and it's difficult to keep up with all the deals.

  • June 05, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the U.K.'s oldest Indian restaurant launch an appeal against King Charles III's property company in an effort to stop its eviction, trustees of a bankrupt former EY tax partner file a claim against his wife, and 37 leading insurers bring a lawsuit against agrichemical company Syngenta over an insurance dispute. Here, Law360 looks at these and other new claims in the U.K.

  • June 05, 2026

    Judge Slams Gov't For 'Pretextual' Immigration Filing Pause

    A Rhode Island federal judge ruled on Friday that U.S. Citizenship and Immigration Services' indefinite hold on processing immigration applications for individuals from the 39 countries on President Donald Trump's travel ban list is unlawful.

  • June 05, 2026

    4 Argument Sessions For Benefits Attys To Watch In June

    The Ninth Circuit will hear from a benefits administrator that claims federal law preempts state-law data breach claims, and Amazon will defend its win in a military leave bias suit at the Second Circuit. Here, Law360 looks at cases being argued in June that benefits attorneys should have on their radar.

  • June 04, 2026

    Trump Era Worse Than McCarthy For Speech, Law Dean Says

    The dean of UC Berkeley's law school told an audience of lawyers and artists on Thursday that America is experiencing "an unprecedented assault on the Constitution, on the First Amendment, and on freedom of speech," comparing the country under President Donald Trump unfavorably to the McCarthy era.

  • June 04, 2026

    Meta Says Section 230 Foils Social Media Addiction Verdict

    Meta urged a Los Angeles judge on Thursday to toss a landmark verdict against the social media giant and Google for harming a young woman's mental health, saying it deserves a total victory under Section 230 because the plaintiff was addicted to third-party content, not the platforms themselves.

  • June 04, 2026

    Generics Cos. Get More Freedom In High Court Patent Ruling

    The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics companies to avoid such suits and creates hurdles for branded companies pursuing infringement litigation, attorneys say.

  • June 04, 2026

    Eli Lilly's 'Overbroad' Weight Drug TM Deal Rejected

    A Washington federal judge has refused to sign off on a deal to settle trademark claims brought by Eli Lilly against two Seattle-area medical clinics, saying the associated consent decree was "overbroad" and contained an even more sweeping injunction.

  • June 04, 2026

    Feds Tout Medicaid Fraud Crackdown In Ohio, Slam Hawaii

    The Trump administration on Thursday praised Ohio's fight against Medicaid fraud and said Hawaii was doing too little, as federal officials pushed states to ramp up anti-fraud prosecutions or risk the loss of federal funding.

Expert Analysis

  • 2 Discovery Rulings Break With Heppner On AI Privilege Issue

    Author Photo

    While a New York federal court’s recent ruling in U.S. v. Heppner suggests that some litigants’ communications with AI tools are discoverable, two other recent federal court decisions demonstrate that such interactions generally qualify for work-product protection under the Federal Rules of Civil Procedure, says Joshua Dunn at Brown Rudnick.

  • Bid Protest Spotlight: Evidence, Tailored Talks, Materiality

    Author Photo

    In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions tailored to individual proposals, and misrepresentation claims involving factors irrelevant to the agency's decision.

  • Series

    Isshin-Ryu Karate Makes Me A Better Lawyer

    Author Photo

    My involvement in martial arts, specifically Isshin-ryu, which has principles rooted in the eight codes of karate, has been one of the most foundational in the development of my personality, and particularly my approach to challenges — including in my practice of law, says Kaitlyn Stone at Barnes & Thornburg.

  • Class Actions At The Circuit Courts: April Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy identifies practice tips from three recent rulings involving allegations of racial discrimination in mortgage applications, health insurance networks and actual cash value losses.

  • Fraud Enforcement, Sentencing Face Unusual Convergence

    Author Photo

    The Trump administration’s newly created task force to eliminate fraud and the U.S. Sentencing Commission’s recent proposals to scale back certain elements of the federal sentencing framework seem to point in opposite directions, creating a collision of policy priorities that may reshape how fraud cases are charged, negotiated and sentenced for years to come, says David Tarras at Tarras Defense.

  • Peptide Policy Is Shifting Toward Sanctioned Compounding

    Author Photo

    The policy landscape for peptides is undergoing a significant shift under the Trump administration, moving toward a complex system of verified compounding and complementary enforcement that will likely bring peptides firmly back into the sphere of legitimate consumer products, say attorneys at Sheppard.

  • Keys To Building Defensible Psychedelic Therapy Programs

    Author Photo

    Given the rapidly evolving legal environment for psychedelic therapies and heightened liability and compliance risks facing providers, meticulous documentation, robust risk management protocols, and proactive engagement with professional organizations and insurers are essential strategies, say Kimberly Chew at Husch Blackwell and L. Alison McInnes at Mindful Health Solutions.

  • Opinion

    State Bars Need To Get Specific About AI Confidentiality

    Author Photo

    Lawyers need to put actual client information into artificial intelligence tools to get their full value, but they cannot confidently do so until state bars offer clear, formal authority on which plan tiers of the three most popular generative AI tools are safe to use when sharing specific client details, says attorney Nick Berk.

  • Trump Order Signals Tougher Benefits Fraud Probes

    Author Photo

    A recent order from President Donald Trump establishing a federal taskforce for addressing fraud in federally funded benefit programs emphasizes interagency information sharing, potentially affecting a broad range of areas including government contracts, administrative law considerations and False Claims Act cases, say attorneys at Morgan Lewis.

  • Opinion

    Judicial Restraint Anchors Constitutional Order

    Author Photo

    Contrasting opinions in two recent U.S. Supreme Court rulings — Trump v. CASA and Bost v. Illinois State Board of Elections — demonstrate how the judiciary’s constitutionally entrusted role can easily be preserved or disrupted, and invite renewed attention to the enduring importance of judicial restraint, says Ninth Circuit Judge J. Clifford Wallace.

  • The Evolution Of States' Workplace Violence Prevention Laws

    Author Photo

    Utah's new law requiring hospitals to implement comprehensive workplace violence reporting systems continues a broader trend of state efforts to expand workplace protections in the absence of sufficient federal regulations, say attorneys at Ogletree.

  • Series

    Alpine Skiing Makes Me A Better Lawyer

    Author Photo

    Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.

  • Weighing The Practical Implications Of SC Kids' Privacy Law

    Author Photo

    South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.

  • FDA Guidance May Move Goalposts For Form 483 Responses

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.

  • 2 Strands Of Patent Law In High Court's 'Skinny Label' Case

    Author Photo

    Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction between two different strands of intellectual property law — analogizing a patent to either a property deed or a home, says Jonas McDavit at Spencer West.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.